Stephen D. Rubin

8.8k citations
17 papers · 4.2k · 2 hit papers · h-index 13

Impact in

  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • HER2/EGFR in Cancer Research 5
    • Cancer Treatment and Pharmacology 2
    • Lung Cancer Treatments and Mutations 3
    • Renal cell carcinoma treatment 2
    • Brain Metastases and Treatment 2

Stephen D. Rubin

17 papers receiving 4.1k citations

Stephen D. Rubin's Hit Papers

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update 2013 · 363 citations
3630+6+13Years since publication50010001.5k2.0k2.5k

Peers

Stephen D. Rubin
Comparison fields: 5 of 106
  • Oncology 2.4k
  • Cancer Research 559
  • Pulmonary and Respiratory Medicine 1.2k
  • Reproductive Medicine 262
  • Genetics 312
Replace Ulrik Lassen with:
Ulrik Lassen Denmark
Allen Lee Cohn United States
Dimosthenis Skarlos Greece
Andréa Varga France
Drew Rasco United States
Gilles Romieu France
Jean-Pascal Machiels Belgium
Erika Hamilton United States
Luc Dirix Belgium
Richard A. Messmann United States
Stephen D. Rubin relative to Ulrik Lassen Denmark Ulrik Lassen's profile →
Citations per field
00.5×3.2×
Ulrik Lassen · 1×
Citations per year

Countries citing papers authored by Stephen D. Rubin

Since Specialization
Citations

This map shows the geographic impact of Stephen D. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Rubin more than expected).

Fields of papers citing papers by Stephen D. Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Rubin. The network helps show where Stephen D. Rubin may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen D. Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen D. Rubin Line = papers co-authored together Stephen D. Rubin links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Hit paper breakdown →
20062638
2
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
Hit paper breakdown →
2013363
3 2018257
4 2005172
5 2011171
6 2011131
7 2004115
8 2003101
9 200489
10 201255
11 200842
12 200539
13 201226
14 20145
15
Lapatinib prevents the metastatic colonization of EGFR+ and Her-2+ breast cancer cells in the brain.
20074
16 20123
17 20121

About Stephen D. Rubin

Stephen D. Rubin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Endocrinology, Diabetes and Metabolism and Reproductive Medicine, having authored 17 papers that have together received 4.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Lung Cancer Treatments and Mutations (3 papers), Renal cell carcinoma treatment (2 papers), Hormonal and reproductive studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Brain Metastases and Treatment (2 papers), Hypothalamic control of reproductive hormones (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (559 citations), Pulmonary and Respiratory Medicine (1.2k citations), Reproductive Medicine (262 citations) and Genetics (312 citations). Stephen D. Rubin has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Mario Campone, Bella Kaufman, Deborah Lindquist, Agnieszka Jagiełło-Gruszfeld, Neville Davidson, Dimosthenis Skarlos, Mark S. Berger, Tadeusz Pieńkowski, Arlene Chan and Charles E. Geyer. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism, Fertility and Sterility, Clinical Cancer Research and Clinical Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact